Dare Bioscience Inc.

07/12/2021 | Press release | Distributed by Public on 07/12/2021 03:49

Daré Announces Collaborative Research Agreement (CRADA) for the Pivotal Phase 3 Study of Ovaprene®, an Investigational Hormone-Free Monthly Contraceptive